RiverPark Advisors’s Artivion AORT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-6,467
Closed -$237K 143
2026
Q1
$237K Sell
6,467
-84
-1% -$3.31K 0.09% 81
2025
Q4
$299K Sell
6,551
-111
-2% -$4.94K 0.09% 82
2025
Q3
$282K Sell
6,662
-1,902
-22% -$71.7K 0.12% 63
2025
Q2
$266K Sell
8,564
-1,994
-19% -$54K 0.16% 66
2025
Q1
$260K Buy
10,558
+5,295
+101% +$147K 0.2% 69
2024
Q4
$150K Sell
5,263
-124
-2% -$3.44K 0.12% 94
2024
Q3
$143K Buy
5,387
+3,246
+152% +$84.4K 0.12% 96
2024
Q2
$54.9K Buy
+2,141
New +$48K 0.05% 110

Other funds holding AORT

RiverPark Advisors's AORT Position: Q2 2026 in Review

RiverPark Advisors sold out of Artivion (AORT) in Q2 2026, closing a stake of 6,467 shares — an estimated $237K sold.

RiverPark Advisors first reported a position in AORT in Q2 2024 and held it in 8 quarters. The position peaked at $299K in Q4 2025. 207 funds tracked by Wall St. Rank hold AORT as of Q2 2026.

  • RiverPark Advisors reported no remaining Artivion position as of Q2 2026 after selling out during the quarter.
  • RiverPark Advisors sold 6,467 Artivion shares in Q2 2026, an estimated $237K.
  • RiverPark Advisors first reported a position in Artivion in Q2 2024 and held it in 8 quarters.
  • RiverPark Advisors's Artivion position peaked at $299K in Q4 2025.
  • 207 funds tracked by Wall St. Rank held Artivion as of Q2 2026.

Based on RiverPark Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.